Characterisation of lisdexamfetamine dimesylate use in children, adolescents and adults in Europe

被引：0
|
作者：
Siffel, C. [1 ]
Page, M. [1 ]
Maxwell, T. [1 ]
Thun, B. [2 ]
Kolb, N. [2 ]
Ehlken, B. [2 ]
Rosenlund, M. [3 ]
Von Bredow, D. [2 ]
Keja, J. [4 ]
机构：
[1] Shire, Lexington, MA USA
[2] IQVIA, Hlth Econ & Outcomes Res, Munich, Germany
[3] IQVIA, Hlth Econ & Outcomes Res, Solna, Sweden
[4] IQVIA, Hlth Econ & Outcomes Res, Paris, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.692
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.828
引用
收藏
页码：S551 / S551
页数：1
相关论文
共 50 条
  • [1] Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe
    Siffel, Csaba
    Page, Matthew
    Maxwell, Tricia
    Thun, Barbara
    Kolb, Nikolaus
    Rosenlund, Mats
    von Bredow, Dorothea
    Keja, Jacco
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (07) : 439 - 447
  • [2] Lisdexamfetamine dimesylate: a Treatment Option for Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Germany and Across Europe
    Haege, A.
    Banaschewski, T.
    Dittmann, R. W.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (12) : 676 - 685
  • [3] Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults
    Mattingly, Gregory
    CNS SPECTRUMS, 2010, 15 (05) : 315 - 325
  • [4] Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder
    Najib, Jadwiga
    Didenko, Ekaterina
    Meleshkina, Daria
    Yusupov, Kamila
    Maw, Kateryna
    Ramnarain, Justin
    Tabassum, Maliha
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1717 - 1735
  • [5] Understanding the Effect Size of Lisdexamfetamine Dimesylate for Treating ADHD in Children and Adults
    Faraone, Stephen V.
    JOURNAL OF ATTENTION DISORDERS, 2012, 16 (02) : 128 - 137
  • [6] LISDEXAMFETAMINE DIMESYLATE FOR PRESCHOOL CHILDREN WITH ADHD
    Childress, Ann Catherine
    Kollins, Scott H.
    Wu, James
    Robertson, Brigitte
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S165 - S166
  • [7] DRUG UTILIZATION PATTERN OF LISDEXAMFETAMINE DIMESYLATE IN EUROPE
    Cook, M. N.
    Varughese, S.
    Maxwell, T.
    Thun, B.
    Ehlken, B.
    von Bredow, D.
    Keja, J.
    VALUE IN HEALTH, 2015, 18 (07) : A414 - A414
  • [8] The use of lisdexamfetamine dimesylate for the treatment of ADHD
    Childress, Ann C.
    Sallee, Floyd R.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (01) : 13 - 26
  • [9] Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: randomised withdrawal design
    Coghill, D.
    Banaschewski, T.
    Lecendreux, M.
    Johnson, M.
    Zuddas, A.
    Anderson, C.
    Civil, R.
    Lyne, A.
    Gasior, M.
    Squires, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S431 - S432
  • [10] Lisdexamfetamine dimesylate: hydrolysis, pharmacokinetics and duration of therapeutic action in children and adolescents with ADHD
    Haege, A.
    Dittmann, R. W.
    Pennick, M.
    Sorooshian, S.
    Ermer, J.
    Adeyi, B.
    Squires, L.
    Coghill, D. R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S733 - S734
12345